Rosen BP - Search Results

1

Psychological impact of screening for familial ovarian cancer: reactions to initial assessment.

Erlick Robinson G, Rosen BP, Bradley LN, Rockert WG, Carr ML, Cole DE, Murphy KJ. Erlick Robinson G, et al. Among authors: rosen bp. Gynecol Oncol. 1997 May;65(2):197-205. doi: 10.1006/gyno.1997.4686. Gynecol Oncol. 1997. PMID: 9159325

2

High-dose methotrexate for gestational trophoblastic disease.

Elit L, Covens A, Osborne R, Gerulath A, Murphy J, Rosen B, Sturgeon J. Elit L, et al. Gynecol Oncol. 1994 Sep;54(3):282-7. doi: 10.1006/gyno.1994.1211. Gynecol Oncol. 1994. PMID: 7522198 Clinical Trial.

3

Meta-analysis comparing cisplatin total dose intensity and survival.

Ben-David Y, Rosen B, Franssen E, Einarson T, Szyfer I. Ben-David Y, et al. Gynecol Oncol. 1995 Oct;59(1):93-101. doi: 10.1006/gyno.1995.1273. Gynecol Oncol. 1995. PMID: 7557623

4

Does aggressive therapy improve survival in suboptimal stage IIIc/IV ovarian cancer? A Canadian-American comparative study.

LoCoco S, Covens A, Carney M, Franssen E, Dogde R, Rosen B, Osborne R, Kerr I, Buckman R, Soper J, et al. LoCoco S, et al. Gynecol Oncol. 1995 Nov;59(2):194-9. doi: 10.1006/gyno.1995.0007. Gynecol Oncol. 1995. PMID: 7590472

5

Linkage analysis of 26 Canadian breast and breast-ovarian cancer families.

Tonin P, Moslehi R, Green R, Rosen B, Cole D, Boyd N, Cutler C, Margolese R, Carter R, McGillivray B, et al. Tonin P, et al. Hum Genet. 1995 May;95(5):545-50. doi: 10.1007/BF00223867. Hum Genet. 1995. PMID: 7759076

6

Hereditary and familial ovarian cancer in southern Ontario.

Narod SA, Madlensky L, Bradley L, Cole D, Tonin P, Rosen B, Risch HA. Narod SA, et al. Cancer. 1994 Oct 15;74(8):2341-6. doi: 10.1002/1097-0142(19941015)74:8<2341::aid-cncr2820740819>3.0.co;2-z. Cancer. 1994. PMID: 7922985

7

Differences in the morbidity of radical hysterectomy between gynecological oncologists.

Covens A, Rosen B, Gibbons A, Osborne R, Murphy J, DePetrillo A, Lickrish G, Shaw P, Colgan T. Covens A, et al. Gynecol Oncol. 1993 Oct;51(1):39-45. doi: 10.1006/gyno.1993.1243. Gynecol Oncol. 1993. PMID: 8244172

8

Genetic counselling and testing for susceptibility to breast, ovarian and colon cancer: where are we today?

Cole DE, Gallinger S, McCready DR, Rosen B, Engel J, Malkin D. Cole DE, et al. CMAJ. 1996 Jan 15;154(2):149-55. CMAJ. 1996. PMID: 8548703 Free PMC article. Review.

9

Patients' preferences for therapy in advanced epithelial ovarian cancer: development, testing, and application of a bedside decision instrument.

Elit LM, Levine MN, Gafni A, Whelan TJ, Doig G, Streiner DL, Rosen B. Elit LM, et al. Gynecol Oncol. 1996 Sep;62(3):329-35. doi: 10.1006/gyno.1996.0244. Gynecol Oncol. 1996. PMID: 8812525

10

LETTERS TO THE EDITOR.

Ben-David Y, Rosen B. Ben-David Y, et al. Gynecol Oncol. 1996 Sep;62(3):428-9. doi: 10.1006/gyno.1996.0262. Gynecol Oncol. 1996. PMID: 8812546 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

393 results

Search Page

Filters